Brett Lindstrom: 2nd Congressional District Alternative to Lee Terry
For an alternative to Lee Terry in Nebraska's 2nd Congressional District, check out Brett Lindstrom. more
Pumping Up Politics, Prices: Transcanada Keystone XL Pipeline
From my article of November 2, 2011, “TransCanada Trojan Horse: Keystone XL Pipeline Will Increase Gas Prices“: “The TransCanada Keystone Xl pipeline project will result in increased gas and diesel prices in 15 Midwestern States – to the detriment of those states’ citizens and economies.” While I continue to ponder the question… How much more… more
The New National Past Time: Pipeline Hot Potato
It’s a bird! It’s a plane! No! Wait… Is that a football? No, but it is brown. And it is oblong. Hey, it’s smoking! Wait! It’s a hot potato! It’s America’s new national past time and no, sorry, Husker fans, it is not football. It’s called Pipeline Hot Potato. So, let’s play! Let’s meet our… more
NE Unicameral on TransCanada Pipeline: Torturing Words, Logic & State Sovereignty
“It will be of little avail to the people that the laws are made by men of their own choice if the laws be so voluminous that they cannot be read, or so incoherent that they cannot be understood; if they be repealed or revised before they are promulgated, or undergo such incessant changes that… more
#1 Question for Lee Terry: What DID You Do With That 2010 CRS Report About Pipeline Authority?
UPDATED October 7, 2011: After reading this article, we highly recommend reading the next article in this series, “NE Unicameral on TransCanada Pipeline: Twisting Words & Giving Away Sovereignty“, as there are a number of updates and additional information included in it (we have included some of those updates here) . It’s obvious that the… more
Feeling Surprised & Betrayed By GOP Senate Votes On Food Safety Bill?
By Shelli Dawdy I wish I could say that I find the results of Tuesday’s Senate vote on S-510 a surprise, but I don’t. People have expressed shock that so many Republican Senators voted in favor of granting a lot more power to the FDA, spending $1.4 billion we cannot afford, and likely hurting smaller-sized [...]